Zymeworks (ZYME) Non-Current Deffered Revenue (2021 - 2026)

Zymeworks has disclosed Non-Current Deffered Revenue across 6 years of filings, most recently posting $14.6 million for Q1 2026.

• Non-Current Deffered Revenue for Q1 2026 came in at $14.6 million, changed 0.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.6 million (changed 0.01% YoY), and the FY2025 annual result was $14.6 million, changed 0.01% from the prior year.
• Non-Current Deffered Revenue came in at $14.6 million for Q1 2026 at Zymeworks, roughly flat from $14.6 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $32.9 million in Q3 2022 to a low of $14.6 million in Q4 2025.
• The 5-year median for Non-Current Deffered Revenue is $30.6 million (2022), against an average of $23.9 million.
• Across the five-year window, Non-Current Deffered Revenue grew 7.69% in 2023 and sank 55.66% in 2024, its largest moves.
• Zymeworks' Non-Current Deffered Revenue stood at $30.6 million in 2022, then grew by 7.69% to $32.9 million in 2023, then tumbled by 55.66% to $14.6 million in 2024, then fell by 0.01% to $14.6 million in 2025, then changed by 0.0% to $14.6 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $14.6 million (Q1 2026), $14.6 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.